OHR PHARMACEUTICAL INC - COM NEW (OHRP)

CUSIP: 67778H200

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM NEW
Total 13F shares
2,257,005
Share change
+1,927,037
Total reported value
$30,720,000
Price per share
$13.62
Number of holders
34
Value change
+$26,224,142
Number of buys
28
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 67778H200?
CUSIP 67778H200 identifies OHRP - OHR PHARMACEUTICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q1 2014

As of 31 Mar 2014, OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,257,005 shares. The largest 10 holders included MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, EAM Investors, LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS AG, BOGLE INVESTMENT MANAGEMENT L P /DE/, Scepter Holdings, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CREDIT SUISSE AG/. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.